by Erik Valent | Jan 6, 2021 | Uncategorized
Summary of the context and overall objectives of the project The Horizon 2020 MMpredict initiative was started on November 1st 2016 and included the following consortium partners: SkylineDx, the Department of Haematology of the Erasmus University Medical Centre...
by Erik Valent | Nov 2, 2020 | Uncategorized
After more than 4 years of research, the H2020-funded MMpredict project is successfully implemented and officially concluded as of November 1st, 2020. However, research in the field of multiple myeloma should never stop. Therefore we’ll host a subsequent...
by Erik Valent | Aug 26, 2020 | Uncategorized
The European Commission has validated the amendment request of the MMpredict consortium to extend the project duration with 6 month to 31th of October 2020. Due to the COVID-19 outbreak the finalization of the project was hampered since all planned interactions and...
by Erik Valent | Aug 26, 2020 | Uncategorized
Watch the interesting webinar on personalized medicine organized by Myeloma Patients Europe (MPE). In this webinar, Dr. Francesca Bonello from the Università degli Studi di Torino, Turin, Italy – provided examples of the individualized therapy options including future...
by Erik Valent | Jan 2, 2020 | Uncategorized
Validation of SKY92 high and low risk prognostication in a retrospective, multinational cohort of 155 non-trial multiple myeloma patients Yan-Ting Chen1, Erik T. Valent1, Erik H. van Beers1, Rowan Kuiper1, Stefania Oliva2, Torsten Haferlach3, Wee-Joo Chng4, Martin H....
